Arch Snags $1.46B For Pair Of Biotech-Focused Funds
Arch Venture Partners on Thursday said it has clinched a pair of funds totaling $1.46 billion, with plans to target "transformative" biotechnology businesses....To view the full article, register now.
Already a subscriber? Click here to view full article